NITAZOXANIDE

NITAZOXANIDE was reported 349 times

NITAZOXANIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEWCASTLE DISEASE 1 0.2500
1 BILIARY TRACT INFECTION BACTERIAL 3 0.1364
2 MICROSPORIDIA INFECTION 31 0.0883
3 PARANASAL SINUS ABSCESS 2 0.0870
4 CREATINE KINASE ABNORMAL 2 0.0833
5 PARASITIC TEST POSITIVE 1 0.0769
6 CHORIOMENINGITIS LYMPHOCYTIC 5 0.0725
7 PARASITIC GASTROENTERITIS 9 0.0469
8 HERPES SIMPLEX VIRAEMIA 5 0.0400
9 ISOSPORIASIS 3 0.0385
10 STENT-GRAFT ENDOLEAK 2 0.0370
11 GASTROENTERITIS CRYPTOSPORIDIAL 7 0.0345
12 GASTROENTERITIS SAPOVIRUS 3 0.0345
13 CRYPTOSPORIDIOSIS INFECTION 18 0.0343
14 MEAN ARTERIAL PRESSURE INCREASED 2 0.0286
15 PNEUMOCYSTIS JIROVECII INFECTION 31 0.0259
16 MEAN PLATELET VOLUME ABNORMAL 2 0.0250
17 LEPROMATOUS LEPROSY 2 0.0235
18 NECROTIC LYMPHADENOPATHY 2 0.0167
19 ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA 1 0.0164
20 GIARDIASIS 5 0.0147
21 BASAL GANGLIA STROKE 2 0.0139
22 ENCEPHALITIS BRAIN STEM 2 0.0116
23 BLASTOCYSTIS INFECTION 1 0.0115
24 TUBERCULOSIS LIVER 1 0.0115
25 CYTOMEGALOVIRUS ANTIGEN POSITIVE 2 0.0109
26 HERPES SIMPLEX OESOPHAGITIS 2 0.0108
27 COMA SCALE ABNORMAL 31 0.0107
28 GASTROENTERITIS NOROVIRUS 14 0.0105
29 INFECTIVE EXACERBATION OF BRONCHIECTASIS 3 0.0098
30 AMOEBIASIS 2 0.0085
31 NOROVIRUS INFECTION 12 0.0083
32 BULLOUS LUNG DISEASE 1 0.0080
33 PACHYMENINGITIS 2 0.0077
34 ANTICHOLINERGIC SYNDROME 11 0.0069
35 SPECIFIC GRAVITY URINE DECREASED 1 0.0065
36 MUCOSAL NECROSIS 1 0.0064
37 IMMUNODEFICIENCY COMMON VARIABLE 3 0.0061
38 MEDIASTINUM NEOPLASM 1 0.0060
39 BODY DYSMORPHIC DISORDER 2 0.0053
40 NASAL TURBINATE HYPERTROPHY 2 0.0053
41 SPLEEN CONGESTION 1 0.0052
42 PANCREAS TRANSPLANT REJECTION 1 0.0050
43 OROPHARYNGEAL PLAQUE 2 0.0049
44 LEPROSY 1 0.0048
45 CANDIDA SEPSIS 4 0.0045
46 ZYGOMYCOSIS 2 0.0043
47 HELMINTHIC INFECTION 1 0.0041
48 ILLNESS ANXIETY DISORDER 1 0.0041
49 PHARYNGEAL ABSCESS 2 0.0040
50 ICHTHYOSIS 1 0.0040
51 POSTOPERATIVE FEVER 1 0.0036
52 BURNS FIRST DEGREE 1 0.0035
53 NECROTISING MYOSITIS 3 0.0035
54 ENGRAFTMENT SYNDROME 2 0.0034
55 ENTEROCOLITIS VIRAL 1 0.0033
56 APOPTOSIS 1 0.0032
57 BED REST 1 0.0032
58 MYCOBACTERIUM MARINUM INFECTION 1 0.0031
59 DRUG CLEARANCE DECREASED 4 0.0031
60 PYELONEPHRITIS ACUTE 6 0.0031
61 CENTRAL HYPOTHYROIDISM 1 0.0030
62 LICHEN SCLEROSUS 2 0.0029
63 ACTIVATION SYNDROME 1 0.0029
64 FACIAL DISCOMFORT 2 0.0028
65 BK VIRUS INFECTION 9 0.0027
66 INFECTION PARASITIC 2 0.0026
67 DIARRHOEA INFECTIOUS 2 0.0025
68 DEPENDENCE ON RESPIRATOR 1 0.0025
69 PAPILLOMA VIRAL INFECTION 4 0.0024
70 AUTOIMMUNE THROMBOCYTOPENIA 1 0.0023
71 SYSTEMIC CANDIDA 5 0.0020
72 POST PROCEDURAL DIARRHOEA 1 0.0020
73 PNEUMONIA PSEUDOMONAL 3 0.0020
74 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
75 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 1 0.0019
76 RETROPERITONEAL LYMPHADENOPATHY 1 0.0019
77 IMMUNE-MEDIATED ENCEPHALITIS 1 0.0019
78 LISTERIOSIS 2 0.0018
79 OEDEMATOUS PANCREATITIS 1 0.0018
80 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
81 TRANSPLANT FAILURE 4 0.0016
82 SERUM SICKNESS-LIKE REACTION 1 0.0016
83 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
84 PROCEDURAL VOMITING 1 0.0015
85 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
86 APLASTIC ANAEMIA 8 0.0015
87 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
88 CYSTITIS HAEMORRHAGIC 6 0.0015
89 CLONUS 4 0.0015
90 HAND DERMATITIS 1 0.0014
91 CRANIAL NERVE DISORDER 1 0.0014
92 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
93 JARISCH-HERXHEIMER REACTION 1 0.0014
94 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 7 0.0014
95 CHOLANGITIS ACUTE 1 0.0013
96 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
97 ENDOCARDITIS BACTERIAL 1 0.0013
98 HERPES ZOSTER DISSEMINATED 1 0.0012
99 LYMPHANGITIS 1 0.0012
100 DYSBIOSIS 1 0.0012
101 STAPHYLOCOCCAL SEPSIS 6 0.0012
102 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0012
103 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
104 HEPATORENAL SYNDROME 2 0.0012
105 PULMONARY TOXICITY 8 0.0011
106 LIVER TRANSPLANT REJECTION 2 0.0011
107 INTESTINAL INFARCTION 1 0.0011
108 PNEUMOPERITONEUM 2 0.0011
109 HYPOREFLEXIA 2 0.0010
110 NASAL SEPTUM DEVIATION 2 0.0010
111 GENE MUTATION 2 0.0010
112 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
113 NEUROMYOPATHY 1 0.0009
114 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
115 LARGE INTESTINE PERFORATION 6 0.0009
116 RECTAL ULCER 1 0.0009
117 RENAL TRANSPLANT 3 0.0008
118 PSEUDOMONAS INFECTION 7 0.0008
119 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
120 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
121 VENOOCCLUSIVE DISEASE 2 0.0008
122 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
123 HEPATIC INFECTION 1 0.0008
124 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
125 AZOTAEMIA 3 0.0008
126 BLOOD POTASSIUM ABNORMAL 2 0.0007
127 AREFLEXIA 2 0.0007
128 ELECTRIC SHOCK SENSATION 2 0.0007
129 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
130 OXYGEN SATURATION ABNORMAL 2 0.0007
131 MONOPLEGIA 3 0.0007
132 IMPETIGO 1 0.0007
133 DUODENITIS 2 0.0007
134 FUNGAEMIA 1 0.0006
135 TRANSPLANT REJECTION 5 0.0006
136 LYMPHOCYTE COUNT INCREASED 2 0.0006
137 NEAR DEATH EXPERIENCE 2 0.0006
138 MYCOBACTERIAL INFECTION 1 0.0006
139 GRANULOMA 2 0.0006
140 ERYTHEMA NODOSUM 2 0.0006
141 LYMPHOPENIA 8 0.0006
142 HISTOPLASMOSIS 1 0.0006
143 ILEAL STENOSIS 1 0.0006
144 FEAR OF DISEASE 1 0.0006
145 BLOOD HIV RNA INCREASED 1 0.0006
146 MONOCYTE COUNT INCREASED 2 0.0006
147 TETANY 1 0.0005
148 DISORGANISED SPEECH 1 0.0005
149 OPPORTUNISTIC INFECTION 1 0.0005
150 LEUKOENCEPHALOPATHY 2 0.0005
151 SEROTONIN SYNDROME 10 0.0005
152 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
153 OESOPHAGEAL CANDIDIASIS 2 0.0005
154 LARGE INTESTINAL STENOSIS 1 0.0005
155 CHOLANGITIS SCLEROSING 1 0.0005
156 QUADRIPLEGIA 1 0.0005
157 HYPERPARATHYROIDISM 1 0.0005
158 EYE CONTUSION 1 0.0005
159 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
160 ENTERITIS 3 0.0005
161 HYPERPHOSPHATAEMIA 1 0.0005
162 HEPATIC LESION 2 0.0005
163 HERPES SIMPLEX 3 0.0005
164 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 32 0.0004
165 RHINITIS ALLERGIC 2 0.0004
166 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
167 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
168 CYTOMEGALOVIRUS COLITIS 1 0.0004
169 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
170 NECK SURGERY 1 0.0004
171 ESCHERICHIA BACTERAEMIA 1 0.0004
172 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
173 HAEMATOTOXICITY 4 0.0004
174 VARICELLA 1 0.0004
175 SELF ESTEEM DECREASED 1 0.0004
176 RENAL TUBULAR NECROSIS 4 0.0004
177 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
178 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
179 DISEASE PROGRESSION 46 0.0004
180 CACHEXIA 2 0.0004
181 FAILURE TO THRIVE 2 0.0004
182 BACTERIAL INFECTION 7 0.0004
183 ORAL FUNGAL INFECTION 1 0.0004
184 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
185 HAEMODIALYSIS 3 0.0004
186 RESPIRATORY SYMPTOM 1 0.0004
187 METABOLIC DISORDER 2 0.0003
188 ELECTROLYTE IMBALANCE 4 0.0003
189 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
190 TREATMENT FAILURE 28 0.0003
191 ODYNOPHAGIA 2 0.0003
192 BLOOD CULTURE POSITIVE 1 0.0003
193 CENTRAL VENOUS CATHETERISATION 1 0.0003
194 PATHOGEN RESISTANCE 3 0.0003
195 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
196 MYDRIASIS 4 0.0003
197 CYTOMEGALOVIRUS INFECTION 5 0.0003
198 THERAPEUTIC AGENT TOXICITY 1 0.0003
199 NEPHRITIS 1 0.0003
200 NEUTROPHIL COUNT INCREASED 3 0.0003
201 HELICOBACTER INFECTION 3 0.0003
202 HYPERREFLEXIA 1 0.0003
203 TYPE I HYPERSENSITIVITY 1 0.0003
204 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
205 APPENDICECTOMY 1 0.0003
206 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
207 SCLERODERMA 1 0.0003
208 DRUG RESISTANCE 7 0.0003
209 FACE INJURY 1 0.0003
210 PARANASAL SINUS HYPERSECRETION 1 0.0003
211 HYPOALBUMINAEMIA 2 0.0003
212 COVID-19 PNEUMONIA 3 0.0003
213 PNEUMONIA FUNGAL 1 0.0003
214 SHOCK HAEMORRHAGIC 2 0.0002
215 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
216 MENSTRUAL DISORDER 2 0.0002
217 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
218 TEARFULNESS 1 0.0002
219 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
220 FACIAL PAIN 2 0.0002
221 URINE ABNORMALITY 1 0.0002
222 METABOLIC ACIDOSIS 7 0.0002
223 IMMUNE THROMBOCYTOPENIA 1 0.0002
224 NERVE COMPRESSION 2 0.0002
225 NEPHROGENIC ANAEMIA 1 0.0002
226 HYPOMAGNESAEMIA 3 0.0002
227 COLITIS 8 0.0002
228 PULSE ABSENT 1 0.0002
229 CHOLESTASIS 4 0.0002
230 GASTROINTESTINAL TOXICITY 1 0.0002
231 VULVOVAGINAL PAIN 1 0.0002
232 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
233 IMMUNODEFICIENCY 3 0.0002
234 HEPATIC ENZYME ABNORMAL 1 0.0002
235 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
236 CORONARY ARTERY STENOSIS 1 0.0002
237 KLEBSIELLA INFECTION 1 0.0002
238 LYMPHOMA 3 0.0002
239 FOOD POISONING 1 0.0002
240 NERVE INJURY 2 0.0002
241 MALNUTRITION 2 0.0002
242 NEPHROPATHY TOXIC 2 0.0002
243 CHEST PAIN 33 0.0002
244 CHROMATURIA 4 0.0002
245 REBOUND EFFECT 2 0.0002
246 SKIN TOXICITY 1 0.0002
247 BLOOD URIC ACID INCREASED 1 0.0002
248 HYPOVOLAEMIA 1 0.0002
249 END STAGE RENAL DISEASE 3 0.0002
250 PROCTALGIA 1 0.0002
251 PLATELET COUNT INCREASED 2 0.0002
252 ORAL CANDIDIASIS 2 0.0002
253 IMMUNE SYSTEM DISORDER 2 0.0002
254 SKIN MASS 1 0.0001
255 BRONCHIECTASIS 1 0.0001
256 ACUTE HEPATIC FAILURE 2 0.0001
257 PERIPHERAL COLDNESS 2 0.0001
258 MENTAL STATUS CHANGES 4 0.0001
259 SINUS TACHYCARDIA 2 0.0001
260 GRAFT VERSUS HOST DISEASE 1 0.0001
261 ANOSMIA 2 0.0001
262 MAJOR DEPRESSION 1 0.0001
263 BLINDNESS TRANSIENT 1 0.0001
264 PSYCHIATRIC SYMPTOM 1 0.0001
265 HYPOPHOSPHATAEMIA 1 0.0001
266 SEPSIS 15 0.0001
267 THERAPY NON-RESPONDER 6 0.0001
268 HEPATIC FAILURE 4 0.0001
269 ACIDOSIS 1 0.0001
270 LIPASE INCREASED 1 0.0001
271 THYROID DISORDER 2 0.0001
272 AFFECTIVE DISORDER 1 0.0001
273 SENSORY LOSS 1 0.0001
274 POST PROCEDURAL INFECTION 1 0.0001
275 ESCHERICHIA INFECTION 1 0.0001
276 COAGULOPATHY 2 0.0001
277 ANURIA 1 0.0001
278 MULTI-ORGAN FAILURE 2 0.0001
279 CARDIAC MURMUR 1 0.0001
280 TUMOUR LYSIS SYNDROME 1 0.0001
281 LYMPHOCYTE COUNT DECREASED 2 0.0001
282 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
283 HAEMOLYTIC ANAEMIA 1 0.0001
284 SKIN LESION 3 0.0001
285 BLOOD GLUCOSE ABNORMAL 2 0.0001
286 AGRANULOCYTOSIS 2 0.0001
287 NEPHROPATHY 1 0.0001
288 DIARRHOEA HAEMORRHAGIC 1 0.0001
289 HYPOCALCAEMIA 2 0.0001
290 DIARRHOEA 68 0.0001
291 DISEASE RECURRENCE 5 0.0001
292 CHOKING 2 0.0001
293 RENAL INJURY 3 0.0001
294 DRUG INTERACTION 16 0.0001
295 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
296 EYELID PTOSIS 1 0.0001
297 WEIGHT FLUCTUATION 1 0.0001
298 HALLUCINATION, VISUAL 2 0.0001
299 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
300 NIGHT SWEATS 3 0.0001
301 PHARYNGITIS STREPTOCOCCAL 1 0.0001
302 BIPOLAR DISORDER 1 0.0001
303 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
304 STAPHYLOCOCCAL INFECTION 3 0.0001
305 VIRAL INFECTION 3 0.0001
306 HEPATOTOXICITY 2 0.0001
307 MUSCLE TWITCHING 2 0.0001
308 DELIRIUM 3 0.0001
309 VASCULITIS 1 0.0001
310 WHEEZING 5 0.0001
311 BACTERAEMIA 1 0.0001
312 MUSCLE RIGIDITY 1 0.0001
313 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
314 RENAL IMPAIRMENT 7 0.0001
315 PRESYNCOPE 2 0.0001
316 NEURALGIA 2 0.0001
317 CYTOPENIA 1 0.0001
318 SMALL INTESTINAL OBSTRUCTION 1 0.0001
319 ABNORMAL WEIGHT GAIN 1 0.0001
320 AGEUSIA 2 0.0001
321 LEUKOPENIA 4 0.0001
322 HAEMATEMESIS 2 0.0001
323 SKIN ULCER 2 0.0001
324 DEAFNESS 2 0.0001
325 GASTRITIS 2 0.0001
326 INFECTION 11 0.0001
327 DRUG TOXICITY 1 0.0001
328 DYSPNOEA 41 0.0001
329 SKIN REACTION 1 0.0001
330 PAIN IN JAW 2 0.0001
331 BRONCHOSPASM 1 0.0001
332 PARALYSIS 1 0.0001
333 HYPERTHYROIDISM 1 0.0001
334 ASCITES 2 0.0001
335 RENAL FAILURE 9 0.0001
336 OSTEOPENIA 1 0.0001
337 INSURANCE ISSUE 1 0.0001
338 HYPOKALAEMIA 3 0.0001
339 LIMB DISCOMFORT 2 0.0001
340 ACUTE MYELOID LEUKAEMIA 1 0.0001
341 NERVOUS SYSTEM DISORDER 2 0.0001
342 HYPOTHYROIDISM 2 0.0001
343 MOVEMENT DISORDER 2 0.0001
344 OFF LABEL USE 54 0.0001
345 WEIGHT DECREASED 17 0.0001
346 DRUG LEVEL INCREASED 1 0.0001
347 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
348 ACUTE KIDNEY INJURY 9 0.0001
349 VISION BLURRED 8 0.0001
350 INFLAMMATION 3 0.0001
351 LYMPHADENOPATHY 2 0.0001
352 DRUG ERUPTION 1 0.0001
353 TACHYCARDIA 5 0.0001
354 GOUT 1 0.0001
355 SYNOVITIS 1 0.0001
356 OSTEOMYELITIS 1 0.0001
357 NECK PAIN 3 0.0001
358 DYSARTHRIA 2 0.0001
359 BLOOD URINE PRESENT 1 0.0001
360 CONDITION AGGRAVATED 16 0.0001
361 PROTEINURIA 1 0.0001
362 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
363 POST PROCEDURAL COMPLICATION 1 0.0001
364 DYSTONIA 1 0.0001
365 NEUTROPENIA 7 0.0001
366 HAEMORRHOIDS 1 0.0001
367 ORAL HERPES 1 0.0001
368 DISORIENTATION 2 0.0001
369 DRY MOUTH 4 0.0000
370 BLINDNESS 2 0.0000
371 BODY TEMPERATURE INCREASED 1 0.0000
372 CARDIO-RESPIRATORY ARREST 2 0.0000
373 HAEMORRHAGE 5 0.0000
374 DERMATITIS 1 0.0000
375 RENAL FAILURE ACUTE 2 0.0000
376 EATING DISORDER 1 0.0000
377 JOINT INJURY 1 0.0000
378 LIVER FUNCTION TEST INCREASED 1 0.0000
379 SEPTIC SHOCK 2 0.0000
380 TOOTH DISORDER 1 0.0000
381 RASH MACULO-PAPULAR 1 0.0000
382 INFLUENZA 5 0.0000
383 GASTROINTESTINAL DISORDER 4 0.0000
384 THROAT IRRITATION 2 0.0000
385 HEART RATE IRREGULAR 1 0.0000
386 SKIN DISCOLOURATION 2 0.0000
387 SHOCK 1 0.0000
388 PERICARDIAL EFFUSION 1 0.0000
389 DRUG INEFFECTIVE 57 0.0000
390 RENAL DISORDER 2 0.0000
391 DYSPHAGIA 4 0.0000
392 ANAEMIA 8 0.0000
393 HYPOGLYCAEMIA 2 0.0000
394 ENCEPHALOPATHY 1 0.0000
395 ABASIA 1 0.0000
396 HYPOTENSION 8 0.0000
397 HALLUCINATION 3 0.0000
398 CELLULITIS 2 0.0000
399 SINUSITIS 4 0.0000
400 ABDOMINAL PAIN 9 0.0000
401 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
402 ARTHRITIS 3 0.0000
403 ANHEDONIA 1 0.0000
404 PANCREATITIS 2 0.0000
405 DEPRESSED MOOD 2 0.0000
406 BRADYCARDIA 2 0.0000
407 DEHYDRATION 5 0.0000
408 VOMITING 17 0.0000
409 PROCEDURAL PAIN 1 0.0000
410 THROMBOCYTOPENIA 4 0.0000
411 TOXICITY TO VARIOUS AGENTS 6 0.0000
412 EYE PAIN 2 0.0000
413 INTENTIONAL DOSE OMISSION 1 0.0000
414 RED BLOOD CELL COUNT DECREASED 1 0.0000
415 CONVULSION 2 0.0000
416 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
417 BALANCE DISORDER 3 0.0000
418 NASAL CONGESTION 2 0.0000
419 PSYCHOTIC DISORDER 1 0.0000
420 RESPIRATORY DISORDER 1 0.0000
421 APHASIA 1 0.0000
422 PLEURAL EFFUSION 2 0.0000
423 EMOTIONAL DISORDER 1 0.0000
424 OROPHARYNGEAL PAIN 3 0.0000
425 SWOLLEN TONGUE 1 0.0000
426 PYREXIA 11 0.0000
427 HEAD INJURY 1 0.0000
428 NEUROPATHY PERIPHERAL 3 0.0000
429 CYSTITIS 1 0.0000
430 RHINORRHOEA 2 0.0000
431 DEEP VEIN THROMBOSIS 2 0.0000
432 IMPAIRED HEALING 1 0.0000
433 FEBRILE NEUTROPENIA 2 0.0000
434 BLOOD PRESSURE DECREASED 2 0.0000
435 SKIN DISORDER 1 0.0000
436 GAIT INABILITY 1 0.0000
437 TYPE 2 DIABETES MELLITUS 1 0.0000
438 FLUSHING 3 0.0000
439 MYALGIA 5 0.0000
440 HAEMATURIA 1 0.0000
441 ABDOMINAL PAIN UPPER 6 0.0000
442 GASTRIC DISORDER 1 0.0000
443 NIGHTMARE 1 0.0000
444 NEOPLASM PROGRESSION 1 0.0000
445 ABDOMINAL DISTENSION 3 0.0000
446 HYPOXIA 1 0.0000
447 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
448 CEREBRAL HAEMORRHAGE 1 0.0000
449 RESTLESSNESS 1 0.0000
450 AGITATION 2 0.0000
451 DEPRESSION 6 0.0000
452 CHRONIC KIDNEY DISEASE 2 0.0000
453 GAIT DISTURBANCE 5 0.0000
454 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
455 PALPITATIONS 3 0.0000
456 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
457 ABNORMAL BEHAVIOUR 1 0.0000
458 INFLUENZA LIKE ILLNESS 2 0.0000
459 ASTHENIA 9 0.0000
460 ROAD TRAFFIC ACCIDENT 1 0.0000
461 ABDOMINAL DISCOMFORT 4 0.0000
462 NAUSEA 18 0.0000
463 LIVER DISORDER 1 0.0000
464 PULMONARY OEDEMA 1 0.0000
465 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
466 MUSCLE SPASMS 4 0.0000
467 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
468 PRODUCT USE ISSUE 4 0.0000
469 COMA 1 0.0000
470 RASH ERYTHEMATOUS 1 0.0000
471 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
472 DRUG INTOLERANCE 2 0.0000
473 MALAISE 9 0.0000
474 DRY EYE 1 0.0000
475 SYNCOPE 2 0.0000
476 BLOOD PRESSURE INCREASED 3 0.0000
477 ILLNESS 2 0.0000
478 PARAESTHESIA 3 0.0000
479 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
480 CONFUSIONAL STATE 3 0.0000
481 DISTURBANCE IN ATTENTION 1 0.0000
482 OEDEMA 1 0.0000
483 TREATMENT NONCOMPLIANCE 1 0.0000
484 ARTHROPATHY 1 0.0000
485 URTICARIA 3 0.0000
486 PANCYTOPENIA 1 0.0000
487 COUGH 5 0.0000
488 HYPONATRAEMIA 1 0.0000
489 FLATULENCE 1 0.0000
490 ANXIETY 5 0.0000
491 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
492 BACK PAIN 4 0.0000
493 COVID-19 3 0.0000
494 DYSPHONIA 1 0.0000
495 CHILLS 2 0.0000
496 CATARACT 1 0.0000
497 OEDEMA PERIPHERAL 2 0.0000
498 HYPERSENSITIVITY 3 0.0000
499 HEADACHE 10 0.0000
500 HYPERHIDROSIS 2 0.0000
501 DRY SKIN 2 0.0000
502 NEOPLASM MALIGNANT 1 0.0000
503 INJECTION SITE PRURITUS 1 0.0000
504 SLEEP DISORDER 1 0.0000
505 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
506 RESPIRATORY FAILURE 1 0.0000
507 PRODUCT DOSE OMISSION ISSUE 4 0.0000
508 EPISTAXIS 1 0.0000
509 HOT FLUSH 1 0.0000
510 INCORRECT DOSE ADMINISTERED 3 0.0000
511 DIABETES MELLITUS 1 0.0000
512 PNEUMONIA 4 0.0000
513 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
514 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
515 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
516 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
517 ADVERSE EVENT 1 0.0000
518 NASOPHARYNGITIS 2 0.0000
519 CARDIAC DISORDER 1 0.0000
520 SWELLING 1 0.0000
521 PULMONARY EMBOLISM 1 0.0000
522 MIGRAINE 1 0.0000
523 PRURITUS 4 0.0000
524 FATIGUE 8 0.0000
525 ERYTHEMA 2 0.0000
526 PLATELET COUNT DECREASED 1 0.0000
527 RASH 4 0.0000
528 WEIGHT INCREASED 2 0.0000
529 RHEUMATOID ARTHRITIS 1 0.0000
530 SEIZURE 1 0.0000
531 JOINT SWELLING 1 0.0000
532 EMOTIONAL DISTRESS 1 0.0000
533 INJECTION SITE ERYTHEMA 1 0.0000
534 INSOMNIA 2 0.0000
535 ARTHRALGIA 3 0.0000
536 PAIN IN EXTREMITY 2 0.0000
537 HYPOAESTHESIA 1 0.0000
538 INJECTION SITE PAIN 2 0.0000
539 PAIN 4 0.0000
540 DRUG DOSE OMISSION 1 0.0000
541 CEREBROVASCULAR ACCIDENT 1 0.0000
542 URINARY TRACT INFECTION 1 0.0000
543 NO ADVERSE EVENT 1 0.0000
544 ALOPECIA 1 0.0000
545 CONSTIPATION 1 0.0000
546 DECREASED APPETITE 1 0.0000
547 FEELING ABNORMAL 1 0.0000
548 DIZZINESS 2 0.0000
549 FALL 1 0.0000
550 DEATH 1 0.0000